HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-07-21
DOI
10.3389/fonc.2015.00164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant tissue plasminogen activators (rtPA): A review
- (2015) P Gurman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer
- (2015) Florian Augustin et al. JOURNAL OF CLINICAL PATHOLOGY
- Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis
- (2014) A Schmaus et al. BRITISH JOURNAL OF CANCER
- Transactivation of the Receptor-tyrosine Kinase Ephrin Receptor A2 Is Required for the Low Molecular Weight Hyaluronan-mediated Angiogenesis That Is implicated in Tumor Progression
- (2014) Frances E Lennon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer
- (2014) Frances E. Lennon et al. PLoS One
- Newly Identified Biomarkers for Detecting Circulating Tumor Cells in Lung Adenocarcinoma
- (2014) Yingchun Man et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- The effects of sonic hedgehog signaling pathway components on non-small-cell lung cancer progression and clinical outcome
- (2014) Jinwook Hwang et al. World Journal of Surgical Oncology
- Relationship between Serum Level of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Prognosis in Patients with Lung Cancer
- (2014) Keiko Nunomiya et al. Journal of Cancer
- Role of the extracellular matrix in variations of invasive pathways in lung cancers
- (2013) V.K. de Sá et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer
- (2013) Naohisa Futamura et al. CLINICAL & EXPERIMENTAL METASTASIS
- Activation of the anti-cancer agent upamostat by the mARC enzyme system
- (2013) Danilo Froriep et al. XENOBIOTICA
- Overexpression of the μ-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis
- (2012) Frances E. Lennon et al. ANESTHESIOLOGY
- IDENTIFICATION OF CD133+/NESTIN+ PUTATIVE CANCER STEM CELLS IN NON-SMALL CELL LUNG CANCER
- (2012) Maria Janikova et al. BIOMEDICAL PAPERS-OLOMOUC
- The Urokinase Receptor in the Central Nervous System
- (2012) Marco Archinti et al. CNS & Neurological Disorders-Drug Targets
- Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology
- (2011) Frances E. Lennon et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
- (2011) Martin C. Boonstra et al. CURRENT PHARMACEUTICAL DESIGN
- The Urokinase Receptor System, A Key Regulator at the Intersection between Inflammation, Immunity, and Coagulation
- (2011) Mario Del Rosso et al. CURRENT PHARMACEUTICAL DESIGN
- Hyaluronan matrices in pathobiological processes
- (2011) Aimin Wang et al. FEBS Journal
- Annual Review of Advances in Non-small Cell Lung Cancer Research: A Report for the Year 2010
- (2011) Thomas E. Stinchcombe et al. Journal of Thoracic Oncology
- The Novel Role of the Mu Opioid Receptor in Lung Cancer Progression
- (2010) Biji Mathew et al. ANESTHESIA AND ANALGESIA
- Prognostic Significance of Nestin Expression in Resected Non-small Cell Lung Cancer
- (2010) Shinichiro Ryuge et al. CHEST
- Hyaluronan in human malignancies
- (2010) R.K. Sironen et al. EXPERIMENTAL CELL RESEARCH
- Advances in chemotherapy in advanced non-small-cell lung cancer
- (2010) Paolo Maione et al. EXPERT OPINION ON PHARMACOTHERAPY
- Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients
- (2010) Zhenguang Chen et al. HUMAN PATHOLOGY
- TGF-² Signaling Pathway in Lung Adenocarcinoma Invasion
- (2010) Rebecca L. Toonkel et al. Journal of Thoracic Oncology
- Nestin expression in human tumors and tumor cell lines.
- (2010) O. Krupkova_Jr et al. NEOPLASMA
- Hyaluronic Acid Binding Protein 2 Is a Novel Regulator of Vascular Integrity
- (2009) Nurbek Mambetsariev et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Urokinase plasminogen activator system as a potential target for cancer therapy
- (2009) Ahmed H Mekkawy et al. Future Oncology
- Primary Non-Small Cell Lung Cancer: Review of Frequency, Location, and Time of Recurrence after Radiofrequency Ablation
- (2009) M. D. Beland et al. RADIOLOGY
- Lung cancer: Progress in diagnosis, staging and therapy
- (2009) Stephen G. SPIRO et al. RESPIROLOGY
- Structure and ligand interactions of the urokinase receptor (uPAR)
- (2008) Magnus Kjaergaard Frontiers in Bioscience-Landmark
- Hyaluronidases in cancer biology
- (2008) Robert Stern SEMINARS IN CANCER BIOLOGY
- Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan
- (2008) Raija H. Tammi et al. SEMINARS IN CANCER BIOLOGY
- Factor VII-activating protease (FSAP): Vascular functions and role in atherosclerosis
- (2008) Sandip M. Kanse et al. THROMBOSIS AND HAEMOSTASIS
- Factor VII-activating protease in patients with acute deep venous thrombosis
- (2008) Johannes J. Sidelmann et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started